Healthcare Triangle, Inc. Files Q2 2024 10-Q
Ticker: HCTI · Form: 10-Q · Filed: Aug 19, 2024 · CIK: 1839285
| Field | Detail |
|---|---|
| Company | Healthcare Triangle, Inc. (HCTI) |
| Form Type | 10-Q |
| Filed Date | Aug 19, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, healthcare-technology
TL;DR
HTRI filed its Q2 10-Q. Check financials.
AI Summary
Healthcare Triangle, Inc. filed its 10-Q for the quarterly period ended June 30, 2024. The company, incorporated in Delaware with its principal executive offices in Pleasanton, CA, operates in the computer integrated systems design sector. This filing provides an update on the company's financial performance and operations for the specified quarter.
Why It Matters
This filing provides investors with the latest financial and operational details for Healthcare Triangle, Inc., crucial for understanding the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a publicly traded company filing a 10-Q, there are inherent risks associated with financial reporting and market performance.
Key Numbers
- 001-40903 — Commission file number (Identifies the company's SEC filing registration)
- 84-3559776 — I.R.S. Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Healthcare Triangle, Inc. (company) — Registrant
- June 30, 2024 (date) — Quarterly period end date
- Pleasanton, CA (location) — Principal executive office location
- Delaware (location) — State of incorporation
- 7373 (number) — Standard Industrial Classification Code
FAQ
What is the primary business of Healthcare Triangle, Inc.?
Healthcare Triangle, Inc. operates in the SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN sector, with SIC code 7373.
When is the period covered by this 10-Q filing?
This 10-Q filing is for the quarterly period ended June 30, 2024.
Where are Healthcare Triangle, Inc.'s principal executive offices located?
The principal executive offices are located at 7901 Stoneridge Drive, Suite 220, Pleasanton, CA 94588.
In which state was Healthcare Triangle, Inc. incorporated?
Healthcare Triangle, Inc. was incorporated in Delaware.
What is the company's SEC file number?
The SEC file number for Healthcare Triangle, Inc. is 001-40903.
Filing Stats: 4,468 words · 18 min read · ~15 pages · Grade level 17.2 · Accepted 2024-08-19 16:10:36
Key Financial Figures
- $0.00001 — ange on which registered Common Stock, $0.00001 par value HCTI The Nasdaq Stock Market
Filing Documents
- ea0211536-10q_healthcare.htm (10-Q) — 969KB
- ea021153601ex31-1_healthcare.htm (EX-31.1) — 10KB
- ea021153601ex31-2_healthcare.htm (EX-31.2) — 10KB
- ea021153601ex32-1_healthcare.htm (EX-32.1) — 4KB
- ea021153601ex32-2_healthcare.htm (EX-32.2) — 3KB
- 0001213900-24-070692.txt ( ) — 6357KB
- hcti-20240630.xsd (EX-101.SCH) — 67KB
- hcti-20240630_cal.xml (EX-101.CAL) — 34KB
- hcti-20240630_def.xml (EX-101.DEF) — 315KB
- hcti-20240630_lab.xml (EX-101.LAB) — 567KB
- hcti-20240630_pre.xml (EX-101.PRE) — 315KB
- ea0211536-10q_healthcare_htm.xml (XML) — 840KB
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION
Financial statements
Item 1. Financial statements 1 Unaudited Condensed Consolidated Balance sheets 1 Unaudited Condensed Consolidated Statements of Operations 2 Unaudited Consolidated Statements of Changes in Stockholders' Equity (Deficit) 3 Unaudited Condensed Consolidated Statements of Cash Flows 4 Notes to Unaudited Condensed Consolidated Financial Statements 5
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 32
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 41
Controls and Procedures
Item 4. Controls and Procedures 41
- OTHER INFORMATION
PART II - OTHER INFORMATION
Legal Proceedings
Item 1. Legal Proceedings 42
Risk Factors
Item 1A. Risk Factors 42
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 42
Defaults Upon Senior Securities
Item 3. Defaults Upon Senior Securities 42
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 42
Other Information
Item 5. Other Information 42
Exhibits
Item 6. Exhibits 43
Signatures
Signatures 44 i NOTE ABOUT FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q, including the sections titled "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors," contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, involving substantial risks and uncertainties. The words "believe," "may," "will," "potentially," "plan," "could," "should," "predict," "ongoing," "estimate," "continue," "anticipate," "intend," "project," "expect," "seek," or the negative of these words, or terms or similar expressions conveying uncertainty of future events or outcomes, or that concern our expectations, strategy, plans or intentions, are intended to identify forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated, or expected. When considering forward-looking and in our publicly available filings and press releases. These statements include, among other things, those regarding: our ability to continue to add new customers and increase sales to our existing customers; our ability to develop new solutions and bring them to market in a timely manner; our ability to timely and effectively scale and adapt our existing solutions; our dependence on establishing and maintaining a strong brand; the occurrence of service interruptions and security or privacy breaches and related remediation efforts and fines; system failures or capacity constraints; the rate of growth of, and anticipated trends and challenges in, our business and in the market for our products; our future financial performance, including our expectations regarding our r